Collagen Corp. sales and marketing update

CGEN said the U.S. Health Care Financing Administration (HCFA) approved the reimbursement of Contigen Bard Collagen Implant material to treat intrinsic sphincter deficiency (ISD) for Medicare patients. HCFA will reimburse $310 per syringe, $10 more than the physician's cost, which will help defray administrative expenses, the Palo Alto company said.

Physician fees for treating patients are also reimbursed. ...